带状疱疹中医治疗与护理

本文首先介绍了带状疱疹的临床特征,从中医的角度分析了带状疱疹的病因,引出目前国内主要的中医治疗方法有中药内治法、中药外治法、中药内外结合治疗法、穴位注射法、非药物疗法5种,其中中药内置法主要有分型辩证施治法、基本方随症加减法、专病专方治疗法、中药成药治疗法、中药注射液剂治疗法,介绍了每种中医治疗法的用药类型、治疗效果等,最后分析了带状疱疹的中医护理方法,主要是通过针刺来排毒、活血和止痛.     

针灸、中药外敷综合治疗痤疮58例疗效观察

痤疮属临床常见病,好发于青少年人群,2008年-2010年以来我们采用针灸、局部皮肤针叩刺和中药外敷综合方法治疗痤疮,其原理是活血化瘀宣阳解表,泄火解毒,改善局部血流,促使皮损部位微循环加速,促进炎症和代谢物的吸收、排泄,使痤疮疮消肿化,气机畅达,气血调和;使患者痊愈后面部红润基本恢复正常.     

更昔洛韦治疗带状疱疹的疗效观察

目的:探讨与观察更昔洛韦治疗带状疱疹的临床疗效.方法:选带状疱疹患者110例,随机分为治疗组55例,给予更昔洛韦治疗;对照组55例,给予阿昔洛韦治疗.观察两组临床疗效、主要指标及不良反应.结果:治疗组总有效率为94.55%;对照组总有效率为74.55%,经比较(X2=13.49,p＜0.05)差异具有统计学意义.结论:更昔洛韦治疗带状疱疹具有疗效好,见效快,改善显著等特点,且明显的提高了患者的生活质量,值得临床推广应用.     

脑梗死康复治疗中针灸的应用效果观察

目的:探讨针灸在脑梗死患者康复治疗中的应用效果.方法:选择我院神经内科2009年1月至2011年1月收治的脑梗死患者80例,随机分为两组,对照组40例进行常规治疗,观察组40例在常规治疗的基础上追加针灸治疗,对两组临床效果进行回顾性比较分析.结果:两组患者在治疗前后行MMSE及Barthel对认知功能和日常生活能力进行评定,与治疗前比较,两组治疗后MMSE及Barthel指数均明显改善(P<0.05),观察组MMSE评分和Barthel指数改善更为显著,两组比较差异有统计学意义(P<0.05).结论:在脑梗死康复治疗中采用针灸治疗,可使患者脑流量增强,对脑组织病灶周围脑细胞的缺氧、缺血状况可有效改善,对脑侧支循环的建立有促进作用,提高了机体免疫力.明显改善了患者认识功能和生活能力,有助于病情的康复,明显提高了患者的生存质量.     

针灸推拿配合药物治疗帕金森病的观察

目的:观察针灸推拿配合药物治疗帕金森病的疗效.方法:将11例帕金森病患者随机分为2组.治疗组6例.采用针灸推拿配合药物治疗;对照组5例,单纯采用药物治疗.均以10天为一疗程,6个疗程后观察.结果:治疗组与对照组总有效率比较,差异具有显著意义(P<0.01).结论:针灸推拿配合药物治疗帕金森病疗效显著,值得推广.     

带状疱疹后神经痛的临床治疗研究

带状疱疹后遗神经痛是由水痘疱疹病毒引起的带状疱疹皮肤损害痊愈4-6周常见的后期并发症,在老年患者发病较高,是一种顽固难治性疾病,给患者的心理和生理造成很大的痛苦,目前临床上没有确切的治疗方法,近年来国内外对此作了较广泛研究,取得了一定进展.本人对近年来带状疱疹后神经痛在临床上的研究进展加以综述.     

针灸治疗顽固性呃逆

目的:针对呃逆用针灸治疗顽固性呃逆的疗效.方法:共76例患者治疗组采用针灸经络配穴,并加以补泻手法;对照组用中药汤剂治疗.结果:通过辨证施治,针灸调和阴阳,扶正祛邪,疏通经络,解除病因,停止呃逆,且未复发.结论:针灸治疗顽固性呃逆有显著的疗效.     

针灸按摩配合康复运动治疗脑卒中的效果观察

目的:探讨早期针灸按摩对脑卒中患者语言不利、半身不遂功能恢复的影响.方法:将96例早期脑卒中患者,分为治疗组和对照组,2组患者均接受常规神经内科治疗和早期康复指导,治疗组在此基础上增加针灸按摩治疗.采用1995年全国第四届脑血管病学术会议通过脑卒中患者临床神经功能缺损程度评分标准,在治疗15天(1个疗程)后,对2组患者治疗效果进行评定.结果:与对照组比较,治疗组的评分效率均优于对照组(P<0.05).结论:早期针灸按摩治疗能有效恢复脑卒中患者语言及肢体活动功能.     

浅谈针灸治疗疾病的三要素

本文阐述了针灸治疗疾病的机会，并提出了针灸治疗疾病的三要素：针灸的手法、针久的部位和针灸的时机。     

针灸配合中药治疗周围性面神经炎疗效观察

面神经炎俗称面瘫,可分为中枢性和周围性.前者是脑部病变,后者是感受风寒或病毒感染引起局部神经的血管痉挛、缺血、神经水肿及不同程度的变性,出现面部表情肌瘫痪,即平常所讲的面瘫,主要指周围性面瘫.针灸配合中药治疗面神经炎已被公认为行之有效的治疗方法.笔者采用上述方法治疗面神经炎79例,现报告如下.     

Immunomodulating and antiviral therapy in herpes zoster

Two groups of patients with herpes zoster were followed up. The first group was subjected, beside a symptomatic therapy, to an immunological and antiviral treatment. The control group was treated only symptomatically. The immunological preparations used were: the immunostimulant SRE (Corynebacterium parvum), which stimulated the lymphocytes and macrophages, Moroxidin (Virustat-Paris) and Antiherpin (interferon inductor), which acted by blocking the virus replication. The preparations were indigenous and atoxic. A significant difference between the courses of disease in the two groups was observed, namely, the severity and duration of subjective and objective symptoms were more than double and followed by persistent neurological sequelae in the control group in comparison with the patients of the experimental group.     

Beneficial effects of immunostimulant and antiviral therapy of ophthalmic herpes zoster

In the article, the authors present a relatively uncommon method employed for breast reduction and moulding in gigantomastia. They examine the benefits of the surgical technique based on areolar rotation with a wide superior-lateral dermal areolar flap. The authors point out the fact that postoperative blood supply to the areolas is very good while their sensitivity is preserved.     

Lactation associated with herpes zoster pectoralis

The phenomenon of lactation associated with herpes zoster is unexpected. To our knowledge such an association has been reported only once. A case is reported in whom spontaneous lactation occurred in the ipsilateral breast following herpes zoster. It is believed to have resulted from stimulation of the intercostal nerve endings supplying the overlying skin of the breast.     

The use of capsaicin in herpes zoster ophthalmicus neuralgia

The final stage in the production of a radiotherapy treatment plan must always be an independent check that the linear accelerator settings given on the plan do in fact deliver the required dose distribution. A tool is described that enables rapid checking of diaphragm settings in relation to the patient.     

Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy

We retrospectively studied 18 consecutive cases of acyclovir-resistant zoster. All the patients had chronic skin lesions that failed to heal despite treatment with intravenous acyclovir (30 mg/[kg.d]) in 15 cases and oral acyclovir (4 g/d) in three cases for > 10 days. The mean CD4+ cell count was 20 x 10(6)/L. The mean number of previous zoster episodes was 1.53. Fifteen of the 16 patients evaluable for previous acyclovir treatment had received the drug. Thirteen patients were treated with intravenous foscarnet (200 mg/[kg.d]) for a mean of 17.8 days. Complete healing was observed in 10 (77%) of the 13 treated patients. Zoster relapsed after cessation of foscarnet therapy in five of the 10 responding patients. The median time to relapse was 110 days. Four patients died of varicella-zoster virus-associated visceral complications. These results show that acyclovir-resistant zoster has a poor prognosis but responds well to foscarnet therapy.     

Pain from herpes zoster and postherpetic neuralgia

Under observation there were 82 patients operated on for ulcer disease of the stomach and duodenum. Dissemination of the mucosa with Helicobacter pylori (HP) was studied by means of using the urease test. Before the operation the positive result of the study was obtained in 73 patients (89%). In 1-6 months after the operation the HP infection was found in 29 patients (39.7%). The HP persistence retained in 39.7% of the patients subjected to resection of the stomach in spite of the preoperative treatment including De-nol and Metronidazole. Post-resectional reflux-gastritis and anastomositis were more pronounced in HP carriers. The antireflux variants of anastomoses (transversal, terminolateral gastroduodenal anastomosis and gastrojejunal anastomosis by Roux) were followed by much less HP persistence and less frequent cases of anastomositis and gastritis of the gastric stump.     

Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis

We conducted a review to investigate the prevalence of human immunodeficiency virus (HIV), or acquired immunodeficiency syndrome (AIDS), in patients with herpes zoster ophthalmicus, as well as the incidence of acute retinal necrosis after herpes zoster ophthalmicus. All charts of patients seen at our institution between 1987 and 1992 with a primary diagnosis of herpes zoster ophthalmicus were reviewed. Of 112 patients with herpes zoster ophthalmicus, 29 (26%) had HIV or AIDS. All these patients were younger than 50 years at the time of diagnosis. Five of 29 (17%) immunocompromised patients had acute retinal necrosis after herpes zoster ophthalmicus. No acute retinal necrosis was identified in the nonimmunocompromised patients after herpes zoster ophthalmicus. We recommend that all patients younger than 50 years who have herpes zoster ophthalmicus at initial examination be tested for HIV. Additionally, HIV-infected patients should be monitored closely after herpes zoster ophthalmicus for development of acute retinal necrosis. Long-term oral prophylactic as well as initial high-dose intravenous acyclovir may be appropriate in HIV-infected individuals with herpes zoster.